Good Doctor·Hyperthermic Perfusion | “Elite Pursuit of Excellence” Furnace Program — The 2026 Standardized Spring Training Camp on Body Cavity Hyperthermic Perfusion Therapy (Shanxi Station) Concludes Successfully

“Empowering Clinical Practice, Jointly Driving Development.” Recently, the two-day “Elite Pursuit of Excellence” Melting Pot Program—the 2026 Standardized Spring Training Camp on Intraperitoneal Hyperthermic Perfusion Therapy (Shanxi Station)—concluded successfully in Taiyuan. Clinical experts from the front lines across Shanxi Province gathered to jointly explore and refine techniques, thereby advancing diagnostic and therapeutic practices. This milestone marks a new phase in the standardized promotion of intraperitoneal hyperthermic perfusion therapy (HIPEC) throughout the Shanxi region.

“The Melting Pot Initiative” is our unwavering commitment to empowering clinical practice and fostering collaborative development.

This spring training camp is an important continuation of Xi’an Good Doctor Medical’s efforts to extend its reach to local areas and deepen the practical application of technology, following the previous five sessions of standardized clinical training on hyperthermic intraperitoneal chemotherapy. The “Elite Pursuit of Excellence” crucible program embodies Xi’an Good Doctor Medical’s original training mission: “elite” refers to every dedicated clinical medical staff member; “pursuit of excellence” represents the shared goal of continuous technical improvement and striving for excellence; and “crucible” symbolizes the cultivation philosophy of rigorous refinement and forging into a high-quality professional. The training centers on systematic instruction and standardized hands-on practice, focusing on the standardization of the entire process of hyperthermic intraperitoneal chemotherapy, and establishing a comprehensive clinical empowerment system that integrates theory, hands-on practice, and assessment, thereby helping regional medical personnel hone their skills and align with unified diagnostic and treatment standards.

“ “Led by renowned experts” provides strong support for our precise empowerment and robust technological foundation.

This training program features a distinguished team of industry-leading experts who will deliver in-person instruction. The curriculum is jointly led by the founder of needle-needle microcirculation HIPEC technology—a seasoned authority in deep tumor hyperthermia and whole-body hyperthermia—alongside Professor Liu, who brings 30 years of international clinical experience, and the head nurse of the Day Treatment Center, providing participants with cutting-edge, systematic, and professional clinical guidance.

Figure: A highly experienced expert in the fields of deep tumor hyperthermia and whole-body hyperthermia delivers a specialized lecture on the topic of “Clinical Diagnosis and Treatment of Peritoneal Malignant Tumors.” The course is grounded in the clinical application scenarios of intraperitoneal hyperthermic perfusion therapy and systematically reviews Malignant Peritoneal Tumor classification and clinical characteristics, with a focused analysis of the diagnostic and therapeutic challenges associated with peritoneal metastasis as a common and severe clinical complication, in conjunction with the most frequently occurring malignancies. Peritoneal metastasis The data thoroughly elucidates the clinical necessity and core value of intraperitoneal hyperthermic perfusion therapy.

Figure: Professor Liu, with 30 years of experience in overseas medical practice, delivers a lecture titled “Research Hotspots in Intracavitary Hyperthermic Perfusion Chemotherapy and the Advantages of GD-HIPEC.”
 

The training adopts a small-class, precision teaching model and establishes a three-in-one instructional system that integrates theory, case studies, and hands-on practice. The curriculum covers core topics such as the fundamental principles of intracavitary hyperthermic perfusion therapy, typical clinical cases, and standardized operational protocols, with a strong emphasis on the standardization and practical applicability of the techniques. This approach effectively helps participants solidify their professional foundation and enhance their clinical skills. At the Shanxi session of this spring training camp, a rigorous dual-qualification assessment mechanism—comprising a theoretical written exam and a practical skills evaluation—was strictly implemented. All trainees who successfully completed all learning tasks passed the assessments and were awarded certificates, thereby achieving a closed-loop training process that integrates learning, practice, assessment, and certification.

“Striving for excellence among the elite” is our unwavering commitment to the medical profession.

As a high-tech enterprise integrating R&D, production, and sales, Xi’an Good Doctor Medical has been deeply engaged in the field of tumor hyperthermia for more than ten years, always adhering to its original aspiration of “extending the lives and improving the quality of life of patients with malignant tumors.” Relying on a professional R&D team and extensive clinical experience, it has independently developed a new-generation intracavitary hyperthermic perfusion therapy machine. Its related research has won numerous domestic and international invention patents, and it has established in-depth clinical collaborations with many Grade-III hospitals across China.

The Good Doctor Intracavitary Hyperthermic Perfusion Therapy Machine accurately controls the thermobiological characteristics of tumors by maintaining a subhyperthermic intracavitary temperature of 42–43°C for a continuous 60-minute perfusion cycle, which can induce cancer cell apoptosis. At the same time, it combines local perfusion drug delivery to achieve synergistic enhancement through thermochemotherapy, effectively controlling tumor metastasis and treating malignant pleural and peritoneal effusions. The device employs a closed-loop circulation system coupled with fully automated computer-controlled temperature regulation, thoroughly addressing the pain points of traditional therapies—unstable temperature control, uneven heat distribution, and complex operation—and effectively reducing the risk of postoperative complications such as intestinal obstruction and adhesions. Clinical validation involving over a thousand cases has demonstrated the device’s stable performance, effectively filling the technical gap in postoperative implantation metastasis control and the treatment of malignant body cavity effusions, making it a reliable choice for clinical diagnosis and treatment.

Currently, the Good Doctor thermal perfusion machine has more than 20 independent intellectual property rights, with patent layouts covering multiple regions worldwide. The equipment is compatible with all clinical scenarios in both internal and surgical fields, serving multiple core clinical departments. Thanks to its core advantages of constant temperature stability, minimally invasive operation, and high energy efficiency, it has gained wide recognition and favor from numerous Grade-III hospitals across China.

“Pragmatic action leads to lasting success” is the original aspiration and vision that drive us to dedicate ourselves to clinical practice and safeguard health.

This spring training camp has come to a successful conclusion, further standardizing the clinical application of intraperitoneal hyperthermic perfusion therapy in the Shanxi region and injecting new momentum into the high-quality development of local oncology hyperthermia treatment. In the future, Xi’an Good Doctor Medical will continue to leverage its technological and R&D advantages, deepen the “Elite Pursuit of Excellence” furnace program, accelerate the nationwide regional standardized training layout, promote wider coverage and higher standards for hyperthermic perfusion therapy, empower the construction of an oncology diagnosis and treatment system with professionalism, and continuously contribute to safeguarding people’s lives and health.